Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Opinion · 9 Jun 2023 Mini review · 5 Jun 2023 A Short Note on Multiple Sclerosis
Young adults are most commonly affected by Multiple Sclerosis (MS), a multifaceted and complex condition that affects their capacity for job and social interaction. For MS patients, bodily and cognitive
Research article · 2 Jun 2023 Sex Hormone Therapy in Multiple Sclerosis: A Systematic Review of Clinical Trials
spite of the observed immunomodulatory properties of different sex hormones on Multiple Sclerosis (MS) in different investigations, to date, there has been no study to systematically review the documents
Mini review · 30 May 2023 Neurovascular Unit Dysfunction and Multiple Sclerosis
most common non-traumatic cause of neurological disability in young adults is multiple sclerosis, an inflammatory demyelinating disease of the central nervous system (CNS). Different sclerosis clinical consideration has…
Conference abstract · 18 May 2023 Diagnostic and Treatment - Multiple Sclerosis
score, NRS (Scripps Neurological Rating Scale), GuyâÂ?Â?s Neurological Disability Scale, MSIS-29 (Multiple Sclerosis Impact Scales). McDonaldâÂ?Â?s Criteria, revised in 2017, is commonly used in practice ... also base…
Conference abstract · 18 May 2023 Effect of Human Umbilical Cord Matrix Stem Cell Conditioned Media in Cuprizone Mice Model of Multiple Sclerosis
effect of h-UCMSCs supernatant or conditioned media in the cuprizone mice model of multiple sclerosis. Materials and methods: Adult male C57BL/6 mice (n = 40) were fed a regular ... remyelination potency of multiple…
Opinion · 24 Apr 2023 Understanding Multiple Sclerosis: Symptoms, Diagnosis, and Treatment Options.
Review article · 18 Apr 2023 Study Protocol for a Phase II/III, Randomised, Placebo-Controlled Clinical Trial of Reducing the Frequency of Autoimmune Adverse Events in the Treatment of Multiple Sclerosis with Alemtuzumab using B Cell Depletion: The RAMBLE Trial
Monoclonal antibodies such as alemtuzumab are used for treatment of Multiple Sclerosis (MS) due to their high specificity and efficacy. Whilst highly effective, alemtuzumab causes autoimmune adverse events. A recent…
Research article · 17 Apr 2023 Pleiotropic Genetic Effects between Multiple Sclerosis and Musculoskeletal Traits
Background: Musculoskeletal disorders were commonly reported in patients with multiple sclerosis. However, the underlying etiology linking Multiple Sclerosis (MS) and musculoskeletal disorders is not well studied. With…
Editorial · 29 Mar 2023 Visual Evoked Potentials to the Diagnosis of Multiple Sclerosis
Mini review · 28 Mar 2023 Multiple Sclerosis Patients
Young adults are most commonly affected by Multiple Sclerosis (MS), a multifaceted and complex condition that affects their capacity for job and social interaction. For MS patients, bodily and cognitive
Research article · 28 Feb 2023 Therapy with a Free-Standing Robotic Exoskeleton in People with Advanced Multiple Sclerosis: A Feasibility Study
Background: Evidence for the use of lower limb robotic exoskeletons for people with advanced multiple sclerosis is in its early stages, and to date there have been no published studies ... course of therapy in a…
Short communication · 28 Feb 2023 Treating Multiple Sclerosis
treatment of multiple sclerosis is growing more complex as new disease-modifying medications become available. Using consensus statements is thus recommended. The current consensus statement, developed by the study…
Research article · 27 Feb 2023 Corpus Callosum Area: A Reliable and Feasible Neuroimaging Marker of Cognitive Impairment in Multiple Sclerosis
Background: Several magnetic resonance imaging markers of cognitive impairment have been reported in multiple sclerosis. Nonetheless, measurement often requires volumetry, a time consuming technique that has problems…
Mini review · 21 Feb 2023 Etiology, signs, diagnoses, and cell-based therapy for multiple sclerosis
Commentary · 1 Feb 2023 Multiple Sclerosis (MS): Most Prevalent Immune-Mediated Disorder
Rapid communication · 31 Jan 2023 multiple sclerosis in the of antibody-associated demyelinating syndromes in brain
Mini review · 31 Jan 2023 Health Economics and Disease Burden of Inpatients with Multiple Sclerosis of a Multicenter Study
goal is to gauge the illness burden and health economics of inpatients with multiple sclerosis in China. In 50 centres, a cross-sectional retrospective analysis covered a total ... ratio allowed for cost-utility…
Research article · 31 Jan 2023 Homocysteine Serum Level as a Biomarker of Multiple Sclerosis Disability and Cognitive Impairment
Background: Multiple sclerosis (MS) is considered a progressive irreversible disease that makes neurological dysfunction. Homocysteine is a biomarker that is linked to physical disability and cognitive impairment in…
Editorial · 30 Jan 2023 Discussion on Multiple Sclerosis (Demyelinating Disease)
Mini review · 29 Jan 2023 Neurology Epigenetic Changes: DNA Methylation in Multiple Sclerosis
known as epigenetics. DNA methylation is the most well-known. The cause of multiple sclerosis (MS), a condition with an unknown aetiology, has been hypothesised to involve environmental effects
Short communication · 29 Jan 2023 Improving Remyelination of the Central Nervous System in Multiple Sclerosis
idea is that neural precursors can restore the injured central nervous system of multiple sclerosis patients where the endogenous remyelination process has failed, as a result of recent studies
Opinion · 28 Jan 2023 Pregnancies and Women's Health: Multiple Sclerosis
Background: Hormonal, sex, and pregnancy factors all affect how Multiple Sclerosis (MS) develops. Objective: To examine how the aforementioned elements affect the condition in order to better understand the…

